In a recent study published in the journal Nature Medicine, researchers examine clinical glioblastoma and benign intracranial samples to determine the presence and function of immune cells in the ...
A research team led by Professor Chen Peng from the College of Chemistry and Molecular Engineering at Peking University has ...
The immune system remains seriously out-of-whack—in an inflammatory state of overactivation and impaired ...
Pancreatic cancer uses a sugar-coated disguise to evade the immune system, helping explain why it’s so hard to treat.
To date, no clinically relevant safety issues have been reported other than transient injection site reactions (49%) and headaches (18%). Patients from Part 2 will be evaluated for the progression of ...
Active immunotherapy with ACI-7104.056 induces high anti-a-synuclein antibody levels on average 16-fold higher than placebo after 3 immunizations 100% of patients receiving ACI-7104.056 responded ...
AC Immune (ACIU) to host symposium highlighting the company’s industry-leading pipeline of active immunotherapies for precision prevention of neurodegenerative diseases Multiple presentations at the ...
The loss of immune tolerance with upregulation of immune response can lead to the immune-active, HBeAg-positive stage of chronic hepatitis B. For persons who acquired chronic hepatitis B as a neonate, ...
A research team led by Professor Chen Peng from the College of Chemistry and Molecular Engineering at Peking University has developed a novel cancer immunotherapy strategy that forces tumors to expose ...
AC Immune Reports Further Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease Active immunotherapy with ACI-7104.056 induces high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback